Common Contracts
35 similar Employment Agreement contracts by Matinas BioPharma Holdings, Inc., Provention Bio, Inc., Regado Biosciences Inc, others
EMPLOYMENT AGREEMENTEmployment Agreement • March 8th, 2022 • Matinas BioPharma Holdings, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”), entered into on October 22, 2020 with the commencement of employment to begin as of December 1, 2020 (the “Commencement Date”), is by and between MATINAS BIOPHARMA HOLDINGS, INC., a Delaware corporation (the “Company”) and Dr. Hui Liu (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 8th, 2022 • Matinas BioPharma Holdings, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”), entered into on December 3, 2021 with the commencement of employment to begin as of December 6, 2021 (the “Commencement Date”), is by and between MATINAS BIOPHARMA HOLDINGS, INC., a Delaware corporation (the “Company”) and Thomas Hoover (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • August 6th, 2020 • Provention Bio, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”), effective August 3, 2020 (the “Effective Date”), is by and between PROVENTION BIO, INC., a Delaware corporation (the “Company”) and Heidy Abreu King-Jones, Esq. (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • June 16th, 2020 • DelMar Pharmaceuticals, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”), dated April 8, 2016 and effective on the date of consummation of the initial closing of the private placement offering of the Company’s common stock (the “Effective Date”), is by and between ADGERO BIOPHARMACEUTICALS HOLDINGS, INC., a Delaware corporation (the “Company”) and Steven J. Rychnovsky (the “Executive”).
FIRST AMENDED EMPLOYMENT AGREEMENTEmployment Agreement • June 11th, 2020 • Provention Bio, Inc. • Pharmaceutical preparations • California
This EMPLOYMENT AGREEMENT (this “Agreement”), effective June 9, 2020 (the “Effective Date”), is by and between PROVENTION BIO, INC., a Delaware corporation (the “Company”) and Eleanor Ramos (the “Executive”).
FIRST AMENDED EMPLOYMENT AGREEMENTEmployment Agreement • June 11th, 2020 • Provention Bio, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”), effective June 9, 2020 (the “Effective Date”), is by and between PROVENTION BIO, INC., a Delaware corporation (the “Company”) and Jason Hoitt (the “Executive”).
FIRST AMENDED EMPLOYMENT AGREEMENTEmployment Agreement • June 11th, 2020 • Provention Bio, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”), effective June 10, 2020 (the “Effective Date”), is by and between PROVENTION BIO, INC., a Delaware corporation (the “Company”) and Francisco Leon (the “Executive”).
FIRST AMENDED EMPLOYMENT AGREEMENTEmployment Agreement • June 11th, 2020 • Provention Bio, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”), effective June 9, 2020 (the “Effective Date”), is by and between PROVENTION BIO, INC., a Delaware corporation (the “Company”) and Andrew Drechsler (the “Executive”).
EX-10.15 19 ex10-15.htm EMPLOYMENT AGREEMENTEmployment Agreement • May 5th, 2020 • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”), dated June 20, 2017 and effective on July 1, 2017 (the “Effective Date”), is by and between PROVENTION BIO, Inc., a Delaware corporation (the “Company”) and Dr. Eleanor L. Ramos (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • January 9th, 2020 • CytoDyn Inc. • Pharmaceutical preparations • Washington
This EMPLOYMENT AGREEMENT (this “Agreement”), dated as of November 13, 2019 (the “Effective Date”), is by and between CYTODYN INC., a Delaware corporation (the “Company”) and Craig Eastwood (the “Employee”).
EMPLOYMENT AGREEMENTEmployment Agreement • January 8th, 2020 • Provention Bio, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”), effective January 7, 2020 (the “Effective Date”), is by and between PROVENTION BIO, INC., a Delaware corporation (the “Company”) and Jason Hoitt (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • February 25th, 2019 • Matinas BioPharma Holdings, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”), entered into on February 22, 2019 with the commencement of employment to begin as of February 25, 2019 (the “Commencement Date”), is by and between MATINAS BIOPHARMA HOLDINGS, INC., a Delaware corporation (the “Company”) and James J. Ferguson III, MD, FACC, FAHA (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • January 3rd, 2019 • Matinas BioPharma Holdings, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”), entered into on December 31, 2018 with the commencement of employment to begin as of January 2, 2019 (the “Commencement Date”), is by and between MATINAS BIOPHARMA HOLDINGS, INC., a Delaware corporation (the “Company”) and Keith A. Kucinski, CPA (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 9th, 2018 • Provention Bio, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”), dated April 25, 2017 and effective on the date of consummation of the initial closing of the private placement offering of the Company’s Series A Preferred Stock, par value $0.0001 per share (the “Effective Date”), is by and between PROVENTION BIO, Inc., a Delaware corporation (the “Company”) and ASHLEIGH PALMER (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 27th, 2018 • Matinas BioPharma Holdings, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”), dated as of March 22, 2018 (the “Effective Date”), is by and between MATINAS BIOPHARMA HOLDINGS, INC., a Delaware corporation (the “Company”) and Jerome Jabbour (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • February 12th, 2018 • Provention Bio, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”), dated June 20, 2017 and effective on July 1, 2017 (the “Effective Date”), is by and between PROVENTION BIO, Inc., a Delaware corporation (the “Company”) and Dr. Eleanor L. Ramos (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • February 12th, 2018 • Provention Bio, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”), dated September 21, 2017 and effective on September 5, 2017 (the “Effective Date”), is by and between PROVENTION BIO, Inc., a Delaware corporation (the “Company”) and Andrew Drechsler (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • February 14th, 2017 • Adgero Biopharmaceuticals Holdings, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”), dated April 8, 2016 and effective on the date of consummation of the initial closing of the private placement offering of the Company’s common stock (the “Effective Date”), is by and between ADGERO BIOPHARMACEUTICALS HOLDINGS, INC., a Delaware corporation (the “Company”) and Steven J. Rychnovsky (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • November 3rd, 2016 • Adgero Biopharmaceuticals Holdings, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”), dated April 8, 2016 and effective on the date of consummation of the initial closing of the private placement offering of the Company’s common stock (the “Effective Date”), is by and between ADGERO BIOPHARMACEUTICALS HOLDINGS, INC., a Delaware corporation (the “Company”) and Frank G. Pilkiewicz, Ph.D. (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • September 1st, 2015 • Matinas BioPharma Holdings, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”), dated as of September 1, 2015 (the “Effective Date”), is by and between MATINAS BIOPHARMA HOLDINGS, INC., a Delaware corporation (the “Company”) and Raphael J. Mannino (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 18th, 2015 • Matinas BioPharma Holdings, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”), dated as of March 12, 2015 (the “Effective Date”), is by and between MATINAS BIOPHARMA HOLDINGS, INC., a Delaware corporation (the “Company”) and Douglas F. Kling (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • January 7th, 2015 • Cytodyn Inc • Pharmaceutical preparations • Washington
This EMPLOYMENT AGREEMENT (this “Agreement”), dated as of January 6, 2015 (the “Effective Date”), is by and between CYTODYN INC., a Colorado corporation (the “Company”) and Michael D. Mulholland (the “Executive”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • January 7th, 2015 • Cytodyn Inc • Pharmaceutical preparations • Washington
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”), dated as of January 6, 2015 (the “Effective Date”), is by and between CYTODYN INC., a Colorado corporation (the “Company”) and Nader Pourhassan (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 23rd, 2014 • Regado Biosciences Inc • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”), dated May 19, 2014 and effective as of the Commencement Date (as defined in Section 1.2), is by and between REGADO BIOSCIENCES, INC., a Delaware corporation (the “Company”) and Nicholas J. Pelliccione, Ph.D. (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 1st, 2014 • Regado Biosciences Inc • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”), dated April 25, 2014 and effective as of the Commencement Date (as defined in Section 1.2), is by and between REGADO BIOSCIENCES, INC., a Delaware corporation (the “Company”) and R. DON ELSEY (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • December 20th, 2013 • Matinas BioPharma Holdings, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”), dated as of September 3, 2013 and effective as of October 4, 2013 (the “Effective Date”), is by and between MATINAS BIOPHARMA HOLDINGS, INC., a Delaware corporation (the “Company”) and Jerome Jabbour (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • December 9th, 2013 • Regado Biosciences Inc • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”), dated December 5, 2013 and effective as of the Commencement Date (as defined in Section 1.2), is by and between REGADO BIOSCIENCES, INC., a Delaware corporation (the “Company”) and MICHAEL A. METZGER (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • October 4th, 2013 • Matinas BioPharma Holdings, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”), dated July 30, 2013 and effective on the date of the initial closing of the private placement offering of the Company’s common stock (the “Effective Date”), is by and between MATINAS BIOPHARMA HOLDINGS, INC., a Delaware corporation (the “Company”) and Roelof Rongen (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • October 4th, 2013 • Matinas BioPharma Holdings, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”), dated July 30, 2013 and effective on the date of the initial closing of the private placement offering of the Company’s common stock (the “Effective Date”), is by and between MATINAS BIOPHARMA HOLDINGS, INC., a Delaware corporation (the “Company”) and George Bobotas, PhD (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • October 4th, 2013 • Matinas BioPharma Holdings, Inc. • Pharmaceutical preparations • New Jersey
This EMPLOYMENT AGREEMENT (this “Agreement”), dated July 30, 2013 and effective on the date of the initial closing of the private placement offering of the Company’s common stock (the “Effective Date”), is by and between MATINAS BIOPHARMA HOLDINGS, INC., a Delaware corporation (the “Company”) and Abdel A. Fawzy, PhD (the “Executive”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • May 17th, 2013 • Regado Biosciences Inc • Pharmaceutical preparations • New Jersey
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”), dated May 16, 2013 and effective on the date of consummation of the initial public offering of the Company’s common stock (the “Effective Date”), is by and between REGADO BIOSCIENCES, INC., a Delaware corporation (the “Company”) and STEVEN L. ZELENKOFSKE, D.O. (the “Executive”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • May 17th, 2013 • Regado Biosciences Inc • Pharmaceutical preparations • New Jersey
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”), dated May 16, 2013 and effective on the date of consummation of the initial public offering of the Company’s common stock (the “Effective Date”), is by and between REGADO BIOSCIENCES, INC., a Delaware corporation (the “Company”) and ELLEN MCDONALD (the “Executive”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • May 17th, 2013 • Regado Biosciences Inc • Pharmaceutical preparations • New Jersey
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”), dated May 16, 2013 and effective on the date of consummation of the initial public offering of the Company’s common stock (the “Effective Date”), is by and between REGADO BIOSCIENCES, INC., a Delaware corporation (the “Company”) and CHRIS COURTS (the “Executive”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • May 17th, 2013 • Regado Biosciences Inc • Pharmaceutical preparations • New Jersey
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”), dated May 16, 2013 and effective on the date of consummation of the initial public offering of the Company’s common stock (the “Effective Date”), is by and between REGADO BIOSCIENCES, INC., a Delaware corporation (the “Company”) and DAVID J. MAZZO, Ph.D. (the “Executive”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • May 17th, 2013 • Regado Biosciences Inc • Pharmaceutical preparations • New Jersey
This AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”), dated May 16, 2013 and effective on the date of consummation of the initial public offering of the Company’s common stock (the “Effective Date”), is by and between REGADO BIOSCIENCES, INC., a Delaware corporation (the “Company”) and CHRISTOPHER RUSCONI, Ph.D. (the “Executive”).
